Cardiol Rev. 2008 Nov-Dec;16(6):273-9.

Toll-like receptors: new therapeutic targets for the treatment of atherosclerosis, acute coronary syndromes, and myocardial failure.

Source

Department of Internal Medicine, Oregon Health and Science University, Portland, Oregon, USA.

Abstract

The toll-like receptors (TLRs) are a class of transmembrane molecules that have important functions in both innate and acquired immunity. As part of the body's normal immune defense against microbial pathogens, stimulation of these receptors will trigger the inflammatory response cascade and the release of cytokines. Activation of these receptors also plays a role in a variety of systemic inflammatory diseases such as asthma, sepsis, atherosclerosis, acute coronary artery disease, and left ventricular remodeling. Pharmacologic approaches to modify the actions of TLRs are now under consideration as potential treatments for inflammatory systemic diseases that include atherosclerosis. At the same time, it is essential to characterize the benefits and risks of modifying such an important part of the body's innate immune system.

PMID:: 18923230; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Education

New England Research Institutes Inc.

Medical

Supplemental Content

Related citations

Review [Toll-like receptors and their role in regulation of the inflammatory response in sepsis]. [Anestezjol Intens Ter. 2008]
Review [Toll-like receptors and their role in regulation of the inflammatory response in sepsis].
Krawczyk-Michalak K, Glapiński A, Brzezińska-Błaszczyk E. Anestezjol Intens Ter. 2008 Oct-Dec; 40(4):253-59.
Review Role of Toll-like receptors in infection and immunity: clinical implications. [Drugs. 2006]
Review Role of Toll-like receptors in infection and immunity: clinical implications.
Cristofaro P, Opal SM. Drugs. 2006; 66(1):15-29.
Review Role of Toll like receptor signaling pathway in ischemic coronary artery disease. [Front Biosci. 2008]
Review Role of Toll like receptor signaling pathway in ischemic coronary artery disease.
Satoh M, Ishikawa Y, Minami Y, Takahashi Y, Nakamura M. Front Biosci. 2008 May 1; 13:6708-15. Epub 2008 May 1.
Review Toll-like receptor signalling and the clinical benefits that lie within. [Inflamm Res. 2007]
Review Toll-like receptor signalling and the clinical benefits that lie within.
Verstak B, Hertzog P, Mansell A. Inflamm Res. 2007 Jan; 56(1):1-10.
Review [Toll-like receptors and the significance for clinical medicine]. [Ned Tijdschr Geneeskd. 2005]
Review [Toll-like receptors and the significance for clinical medicine].
Wiersinga WJ, van der Poll T. Ned Tijdschr Geneeskd. 2005 May 21; 149(21):1150-5.

See reviews... See all...

Cited by 4 PubMed Central articles

New role for L-arginine in regulation of inducible nitric-oxide-synthase-derived superoxide anion production in raw 264.7 macrophages. [ScientificWorldJournal. 2011]
New role for L-arginine in regulation of inducible nitric-oxide-synthase-derived superoxide anion production in raw 264.7 macrophages.
Pekarova M, Lojek A, Martiskova H, Vasicek O, Bino L, Klinke A, Lau D, Kuchta R, Kadlec J, Vrba R, et al. ScientificWorldJournal. 2011; 11:2443-57. Epub 2011 Dec 18.
A systems model for immune cell interactions unravels the mechanism of inflammation in human skin. [PLoS Comput Biol. 2010]
A systems model for immune cell interactions unravels the mechanism of inflammation in human skin.
Valeyev NV, Hundhausen C, Umezawa Y, Kotov NV, Williams G, Clop A, Ainali C, Ouzounis C, Tsoka S, Nestle FO. PLoS Comput Biol. 2010 Dec 2; 6(12):e1001024. Epub 2010 Dec 2.
Albumin-based microbubbles bind up-regulated scavenger receptors following vascular injury. [J Biol Chem. 2010]
Albumin-based microbubbles bind up-regulated scavenger receptors following vascular injury.
Anderson DR, Duryee MJ, Anchan RK, Garvin RP, Johnston MD, Porter TR, Thiele GM, Klassen LW. J Biol Chem. 2010 Dec 24; 285(52):40645-53. Epub 2010 Oct 21.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Toll-like receptors: new therapeutic targets for the treatment of atherosclerosi...
Toll-like receptors: new therapeutic targets for the treatment of atherosclerosis, acute coronary syndromes, and myocardial failure.
Cardiol Rev. 2008 Nov-Dec ;16(6):273-9.

PubMed
Regulating payment for home care companionship services: legal authority and pub...
Regulating payment for home care companionship services: legal authority and public policy.
Care Manag J. 2008 ;9(3):122-7.

PubMed
On the other hand.
On the other hand.
Behav Genet. 2005 May ;35(3):343-50.

PubMed
Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws.
Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws.
Ann Intern Med. 2006 May 16 ;144(10):753-61.

PubMed
A brief history and current status of a dental therapy initiative in the United ...
A brief history and current status of a dental therapy initiative in the United States.
J Dent Educ. 2005 Aug ;69(8):857-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Toll-like receptors: new therapeutic targets for the treatment of atherosclerosis, acute coronary syndromes, and myocardial failure.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Education

Medical

Supplemental Content

Related citations

Cited by 4 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information